UNSPSC 51412702: Alteplase

This classification denotes a differentiation inducer with the molecular formula C2569H3894N746O781S40, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1RXS4UE564, more generally known as alteplase. European Medicines Agency schedules alteplase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05378MIG. The term ALTEPLASE is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 3, no. 3, 1989, list 29.

ALTEPLASE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alteplase under HS 35079090 and SITC 51691. As of Q4 2014, ALTEPLASE remains the US FDA Preferred Term for this commodity. Alteplase bears US NLM identifiers UMLS ID C0032143 and NCI Concept Code C39607. SMILES: none.

UNSPSC 51412702 Alteplase is a Commodity code covering pharmaceutical products used in acute medical interventions, though the recent state and local activity under this code shows procurement of a broader basket of advanced life support medications rather than alteplase alone. The City of Tampa's Purchasing Department solicited sealed bids for Advanced Life Support Medications (Bid No. 26-P-00188) to supply Tampa Fire Rescue, requesting four medication line items: Labetalol HCI, Epinephrine, Adenosine, and Diltiazem, with an estimated contract value of $40,000. State and local issuers buying under this code include fire departments and emergency medical services within municipal governments. Vendors must supply medications meeting strict freshness and defect-warranty requirements, with nine-month minimum expiration dating from acceptance and 365-day product warranties, and must handle pickup and replacement of expired stock before the nine-month mark. All deliveries must occur within ten calendar days of order, and pricing must be firm, including shipping and applicable taxes delivered to the jurisdiction's location.

Geographic activity centers on Florida, with the City of Tampa representing the identified recent opportunity. The Tampa Fire Rescue solicitation was posted on April 24, 2026, with an IFB response deadline of April 8, 2026 (note: the due date predates the posting date in the source, indicating a potential data error or addendum). Award will be made to the lowest responsive, responsible bidder within 120 days of bid opening, with an initial one-year contract term and two optional one-year renewals plus up to three unilateral 30-day extensions. The City of Tampa designated the solicitation as a Small Local Business Enterprise sheltered market with a 5 percent bid discount for SLBE participation up to $10,000; bidders using SLBE subcontractors must submit the required forms within ten workdays of notice to award. Vendors must also provide OSHA-compliant Safety Data Sheets and Accessibility Conformance Reports demonstrating WCAG 2.2 Level AA and Section 508 compliance.